Blue Owl Capital (NYSE:OWL) Upgraded to “Outperform” at Keefe, Bruyette & Woods

Blue Owl Capital (NYSE:OWL) was upgraded by Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a research note issued to investors on Tuesday, Marketbeat.com reports. The firm presently has a $23.00 target price on the stock, up from their prior target price of $20.00. Keefe, Bruyette & Woods’ price objective would suggest a potential upside of 26.90% from the stock’s previous close.

OWL has been the subject of a number of other reports. Oppenheimer set a $24.00 price objective on shares of Blue Owl Capital and gave the stock an “outperform” rating in a research note on Wednesday, April 16th. Citigroup lowered their target price on Blue Owl Capital from $30.00 to $23.00 and set a “buy” rating on the stock in a report on Tuesday, April 8th. Wells Fargo & Company boosted their price target on Blue Owl Capital from $19.00 to $20.00 and gave the stock an “equal weight” rating in a report on Friday, May 2nd. JMP Securities reduced their price objective on Blue Owl Capital from $32.00 to $28.00 and set a “market outperform” rating on the stock in a research report on Tuesday, April 8th. Finally, Barclays dropped their price objective on Blue Owl Capital from $29.00 to $20.00 and set an “overweight” rating for the company in a research report on Monday, April 7th. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.33.

Blue Owl Capital Trading Down 4.9%

OWL stock opened at $18.12 on Tuesday. The firm has a 50 day moving average of $18.69 and a 200-day moving average of $21.64. The company has a market cap of $27.87 billion, a price-to-earnings ratio of 106.62, a PEG ratio of 1.23 and a beta of 1.21. Blue Owl Capital has a 12-month low of $14.55 and a 12-month high of $26.73.

Blue Owl Capital (NYSE:OWL) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.03). Blue Owl Capital had a return on equity of 20.82% and a net margin of 4.77%. The firm had revenue of $620.19 million for the quarter, compared to analyst estimates of $636.44 million. Sell-side analysts forecast that Blue Owl Capital will post 0.92 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Blue Owl Capital by 26.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,994,159 shares of the company’s stock worth $39,963,000 after acquiring an additional 420,809 shares during the last quarter. Select Equity Group L.P. acquired a new position in Blue Owl Capital during the first quarter valued at approximately $38,810,000. NewEdge Advisors LLC grew its stake in Blue Owl Capital by 2.3% during the first quarter. NewEdge Advisors LLC now owns 298,378 shares of the company’s stock worth $5,979,000 after buying an additional 6,659 shares during the period. HMI Capital Management L.P. acquired a new stake in shares of Blue Owl Capital in the first quarter worth $30,343,000. Finally, Banque Transatlantique SA acquired a new stake in shares of Blue Owl Capital in the first quarter worth $31,000. 35.85% of the stock is owned by hedge funds and other institutional investors.

Blue Owl Capital Company Profile

Blue Owl Capital Inc operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.